| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.21M | 37.43M | 30.02M | 23.41M | 24.10M | 22.84M |
| Gross Profit | 30.30M | 32.86M | 26.12M | 19.72M | 20.20M | 19.11M |
| EBITDA | 4.46M | 6.70M | 4.40M | 2.04M | 2.06M | 4.33M |
| Net Income | 2.83M | 4.47M | 2.03M | 404.00K | 955.00K | 1.69M |
Balance Sheet | ||||||
| Total Assets | 20.44M | 21.98M | 19.09M | 14.98M | 18.59M | 17.41M |
| Cash, Cash Equivalents and Short-Term Investments | 10.75M | 12.83M | 9.61M | 5.72M | 11.17M | 9.01M |
| Total Debt | 1.13M | 526.00K | 346.00K | 1.46M | 5.01M | 5.08M |
| Total Liabilities | 6.08M | 7.88M | 8.52M | 6.37M | 10.33M | 10.17M |
| Stockholders Equity | 14.36M | 14.10M | 10.57M | 8.61M | 8.26M | 7.23M |
Cash Flow | ||||||
| Free Cash Flow | 3.50M | 4.92M | 5.10M | -1.88M | 3.90M | 3.71M |
| Operating Cash Flow | 3.67M | 5.51M | 5.93M | -628.00K | 4.04M | 3.91M |
| Investing Cash Flow | -627.00K | -595.00K | -833.00K | -1.25M | -138.00K | -198.00K |
| Financing Cash Flow | -1.23M | -1.33M | -1.12M | -3.82M | -1.95M | -1.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £38.32M | 67.27 | 19.89% | 2.29% | 3.32% | -10.58% | |
70 Outperform | £201.73M | 10.47 | 6.46% | 3.68% | 15.99% | ― | |
65 Neutral | £139.14M | 18.54 | 24.52% | 1.09% | -21.19% | -29.54% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | £244.65M | -5.55 | -4.92% | 6.33% | -14.27% | -15466.67% | |
48 Neutral | £16.33M | -0.82 | -37.24% | ― | -0.79% | -100.22% | |
46 Neutral | £12.00M | -0.89 | -3.41% | ― | -25.20% | 78.55% |